观点
药品
药物输送
毒品携带者
红细胞
医学
药理学
免疫学
纳米技术
材料科学
物理
声学
作者
Junjie Yan,Jicheng Yu,Chao Wang,Zhen Gu
标识
DOI:10.1002/smtd.201700270
摘要
Abstract Red blood cells (RBCs), or erythrocytes, have been promising endogenous candidates for drug delivery for more than four decades. Armed with a better understanding of the diverse mechanisms and paths for drug delivery, researchers have achieved great progress in manufacturing RBC‐based carriers, from both the scientific and clinical viewpoints. Here, the loading methods and loading therapeutics by RBC carriers are surveyed, and recent advances in the design of stimuli‐triggered RBC carriers highlighted. Key developing trends and challenges, are also discussed, and an outlook is presented.
科研通智能强力驱动
Strongly Powered by AbleSci AI